文献速递肺外科

局部晚期非小细胞肺癌三联治疗后的慢性肺损伤

Chronic Lung Injury After Trimodality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
PubMed 文献 · Ann Thorac Surg · 2020-10-14

本研究纳入112例接受诱导放化疗后手术的局部晚期非小细胞肺癌患者,术后每6个月复查胸部CT超过1年,评估肺实质损伤。结果显示,术后1年慢性肺损伤(CLI)发生率为84%,34%患者出现进展,空洞形成后10年慢性感染累积发生率达76.4%。

要点

  • 三联治疗后CLI常见,术后1年发生率84%,34%出现进展。
  • 进行性肺纤维化多见于右中下叶切除后,空洞形成是慢性感染前驱。
  • 空洞形成者10年慢性感染累积发生率达76.4%,部分需手术干预。

核心结论

  • CLI是局部晚期非小细胞肺癌三联治疗后的常见并发症,常导致空洞形成并继发难治性慢性感染,部分需手术干预。

研究设计与样本

  • 单中心队列研究,纳入112例接受诱导放化疗后手术的LA-NSCLC患者,术后每6个月复查胸部CT并随访超过1年,回顾全部胸部CT评估肺实质损伤。

主要发现

  • 术后1年CLI见于94例(84%),CLI进展见于38例(34%)。
  • 进行性肺纤维化作为CLI进展的首发表现最常见于右中叶及右下叶切除术后。
  • 空洞形成是进行性肺纤维化之后的表现,慢性感染是CLI的最终阶段。
  • 有空洞形成者10年慢性感染累积发生率为76.4%。
  • 10例慢性感染中包括7例肺曲霉病及2例耐甲氧西林金黄色葡萄球菌或嗜麦芽窄食单胞菌空洞感染。

临床怎么用

  • 三联治疗后应长期CT随访监测CLI及其进展,警惕空洞形成与慢性感染,必要时外科干预。

局限性

  • 为单中心研究,样本量112例,随访以CT影像评估为主,未涉及CLI统一管理方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trimodality therapy is a treatment option for patients with locally advanced non-small cell lung cancer (LA-NSCLC). Thoracic radiation has both early (radiation pneumonitis) and late (chronic lung injury [CLI]) adverse effects on the lung. While CLI is expected to result in various problems in long-term survivors, these manifestations have not been precisely investigated. METHODS: We enrolled 112 LA-NSCLC patients who had received induction chemoradiotherapy followed by surgery, and then undergone follow-up computed tomography (CT) every 6 months for greater than 1 year. All chest CT images were reviewed to evaluate any injury of the pulmonary parenchyma. RESULTS: CLI at 1 year after surgery and its progression were observed in 94 (84%) and 38 (34%) patients, respectively. Progressive lung fibrosis as the first manifestation of CLI progression was most frequent after right middle and lower lobectomy. Cavity formation was the subsequent manifestation after progressive lung fibrosis , and chronic infection was the final stage of CLI. The cumulative rate of chronic infection was 76.4% at 10 years in patients with cavity formation. Ten patients with chronic infection included 7 cases of pulmonary aspergillosis and 2 cases of cavity infections with methicillin-resistant Staphylococcus aureus or Stenotrophomonas maltophilia. Among them, 4 patients required surgical interventions including completion pneumonectomy or fenestration. CONCLUSIONS: CLI is a common incidence after trimodality therapy for LA-NSCLC. CLI frequently results in cavity formation, which is a precursor of highly refractory chronic infections requiring surgical intervention. Appropriate management needs to be established for CLI developing after trimodality therapy.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Soh J, Sugimoto S, Namba K, et al. Chronic Lung Injury After Trimodality Therapy for Locally Advanced Non-Small Cell Lung Cancer. Ann Thorac Surg. 2020. PMID: 33068542. doi:10.1016/j.athoracsur.2020.07.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。